Mutation and Polymorphism Analysis of the Human Homogentisate 1,2-Dioxygenase Gene in Alkaptonuria Patients  by Beltrán-Valero de Bernabé, D. et al.
Am. J. Hum. Genet. 62:776–784, 1998
776
Mutation and Polymorphism Analysis of the Human Homogentisate 1,2-
Dioxygenase Gene in Alkaptonuria Patients
D. Beltra´n-Valero de Bernabe´,1,3 B. Granadino,1,3 I. Chiarelli,4 B. Porfirio,4 E. Mayatepek,5
R. Aquaron,6 M. M. Moore,7 J. J. M. Festen,8 R. Sanmartı´,9 M. A. Pen˜alva,2 and
S. Rodrı´guez de Co´rdoba1,3
1Departamento de Inmunologı´a and 2Departamento de Microbiologı´a Molecular, Centro de Investigaciones Biolo´gicas, Consejo Superior de
Investigaciones Cientı´ficas, and 3Unidad de Patologı´a Molecular, Fundacio´n Jime´nez Dı´az, Madrid; 4Dipartimento di Fisiopatologia Clinica,
Unita di Genetica Umana, Universita degli Studi, Firenze; 5Division of Metabolic Diseases, University Children’s Hospital, Heidelberg;
6Laboratoire de Biologie, Hopital d’Enfants de la Timone, Centre Hospitalier Regional et Universitaire de Marseille, Marseille; 7Clinical
Genetics Service, Institute of Child Health, Bristol Royal Hospital for Sick Children, St. Michael’s Hill, Bristol, United Kingdom; 8Afdeling
Reumatologie, Medisch Spectrum Twente, Enschede, The Netherlands; and 9Servicio de Reumatologia, Hospital Clinic i Provincial de
Barcelona, Barcelona
Summary
Alkaptonuria (AKU), a rare hereditary disorder of phe-
nylalanine and tyrosine catabolism, was the first disease
to be interpreted as an inborn error of metabolism. AKU
patients are deficient for homogentisate 1,2 dioxygenase
(HGO); this deficiency causes homogentisic aciduria,
ochronosis, and arthritis. We cloned the human HGO
gene and characterized two loss-of-function mutations,
P230S and V300G, in the HGO gene in AKU patients.
Here we report haplotype and mutational analysis of the
HGO gene in 29 novel AKU chromosomes. We identi-
fied 12 novel mutations: 8 (E42A, W97G, D153G,
S189I, I216T, R225H, F227S, and M368V) missense
mutations that result in amino acid substitutions at po-
sitions conserved in HGO in different species, 1 (F10fs)
frameshift mutation, 2 intronic mutations (IVS9-
56GrA, IVS9-17GrA), and 1 splice-site mutation
(IVS51GrT). We also report characterization of five
polymorphic sites in HGO and describe the haplotypic
associations of alleles at these sites in normal and AKU
chromosomes. One of these sites, HGO-3, is a variable
dinucleotide repeat; IVS235T/A, IVS525T/C, and
IVS646C/A are intronic sites at which single nucleo-
tide substitutions (dimorphisms) have been detected; and
c407T/A is a relatively frequent nucleotide substitution
in the coding sequence, exon 4, resulting in an amino
acid change (H80Q). These data provide insight into the
origin and evolution of the various AKU alleles.
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Introduction
Alkaptonuria (AKU [MIM 203500]), the first disorder
to be interpreted as a Mendelian recessive trait (Garrod
1902, 1908), is a rare disease in which homogentisate,
an intermediary product in the phenylalanine catabolic
pathway, cannot be further metabolized and causes hom-
ogentisic aciduria, ochronosis, and arthritis. From early
childhood, AKU patients excrete, with their urine, large
quantities of homogentisate, which can be spontane-
ously oxidized to a black pigment that intensely darkens
the urine of these patients. The pigment is also deposited
in several tissues, causing the black pigmentation (och-
ronosis) that is characteristic of AKU patients. With
time, pigment deposition leads to serious damage to the
connective tissues in the spine and large peripheral joints
and results in a disabling arthritis, the effects of which
appear around the 4th decade of the patient’s life and
tend to worsen with age (reviewed in La Du 1995). AKU
patients are deficient for homogentisate 1,2 dioxygen-
ase(HGO [Enzyme Commission 1.13.11.5]) (La Du et
al. 1958), the enzyme that mediates the conversion of
homogentisate to maleylacetoacetate (Knox and Ed-
wards 1955). Recently, we cloned the humanHGO gene
and demonstrated that it is the gene for AKU by showing
that AKU patients in two Spanish pedigrees were ho-
mozygous, or compound heterozygous, for the loss-of-
function mutations P230S and V300G (Ferna´ndez-
Can˜o´n et al. 1996). More recently, two other mutations
in the HGO gene have been identified in three unrelated
Slovak patients, two of whom were reported to be ho-
mozygotes for the frameshift mutation 621insG and one
for the missense mutation G161R (Gehrig et al. 1997).
The humanHGO gene maps to chromosome 3 (3q21-
23) (Ferna´ndez-Can˜o´n et al. 1996). It spans 54,363 bp
and codes for a 1,715-nt transcript, which is split in 14
exons ranging from 35 to 360 bp (Granadino et al.
1997). TheHGO introns, 605–17,687 bp in length, con-
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Table 1
PCR Primers for Genomic Amplification of the HGO Exons (5′r3′)
Exon Forwarda Reverse PCR Product (bp)
1 GGGAATTCTGTAACCGGTTAAATAAGCTTG CTTTAACTCAGCCATTTTCTC 237
2 CATATAGGAATTCTTACCTTAGTAAACTGC GGCAGATCTTTGGCCTGAAAGCTAGTCATCC 242
3 CTGAATTCGTTGGTGGGAAGGTGGGATGC CTGTGGATCCCAGGGGGAAGGAGGCAGCAC 249
4 ACTCTAAGGCTTGTATATCTTGTAT TTCCAATGACCATGGTATTC 230
5 GATGCTATTTATTTAGAAGGTC GCTTTTGCTTGGCATTCAGGCTGCAAATGG 225
6 GGATTCCAAACGTCCCACCGGTCCC CAACTATGTATGTGCATATGTGAC 338
7 CAATGATTTGTGTTATGACG GAAATAAGACAGATTGAAGAATGAAGG 223
8 GGAATTCAAAAGCAAATGCAGCCTTAAGCC GTTGGATCCAGCAGCAGCTGAAACATCTG 260
9 CGGGCTATGGATCCGGGCAGCTTCTTTATAAC CTCAAGCGAGGCTTAGAGGCTTG 217
10 GTGGATCCGCTCTTGACATGAAAG CCTTGCCTGCCAACCCTTTTAC 259
11 CAGAATTCTTACTTCTCCCAAAGG CTGTGGATCCCTCCCACCCAAGCG 318
12 GCATGAAATGTGTGTCATTGTCC CTTTGGCTTGCAAATGTGGCTTGG 239
13 GGGGATCCGTGTTTTACTGGTCTTGCCTTG CATGGTGCCATCGGCAATCCTC 246
14 GGAATTCTTATTGGAAAATTTCACCTACCC GAAGGGATCCAGGCCAACCACAAGGC 589
a In some cases, the HGO sequence has been modified to introduce EcoRI, BamHI, or BglII restriction sites (underlined) for subcloning
of the amplified product.
tain representatives of the major classes of repetitive el-
ements, including several single-sequence repeats (SSR).
Two of these SSRs, a (CT)n repeat in intron 4 (HGO-
1, D3S4496) and a (CA)n repeat in intron 13 (HGO-
2, D3S4497), were found to be polymorphic in the Span-
ish population (Granadino et al. 1997).
Here we have investigated the HGO gene in 29 AKU
chromosomes from 15 unrelated AKU patients and in
104 normal chromosomes of Spanish origin. We report
the detection of 12 previously unreported AKU muta-
tions and the characterization of five novel HGO poly-
morphisms. The analysis of the associations between the
AKU mutations and the HGO polymorphisms provides
useful data for population genetic studies and for in-
vestigating the history of the mutations.
Material and Methods
Samples
Fourteen affected individuals were included in these
studies. They were diagnosed with AKU on the basis of
clinical and radiological examinations and routine anal-
yses for homogentisic aciduria. Four of the patients are
from France, three are from Spain, two are from Ger-
many, and one each are from Italy, the United Kingdom,
Holland, Algeria, and Turkey. We also studied two ob-
ligate carriers, children of an additional AKU patient
from France. At least 40 healthy individuals of Spanish
origin were screened, to verify that the mutations found
in AKU patients were absent in the normal population.
This sample size was increased to 52 individuals, to cal-
culate allele frequencies at the HGO polymorphic sites
and to estimate haplotype frequencies. DNA samples for
all AKU patients, their family members, and normal in-
dividuals were obtained from peripheral blood lympho-
cytes, by standard methods. Blood was collected from
patients and their relatives after informed consent.
PCR Amplification of HGO Exons and Sequencing
Exons of theHGO gene were amplified from genomic
DNA by use of specific primers derived from the 5′ and
3′ intronic sequences (table 1). The annealing tempera-
ture for all primer pairs was 60C. The corresponding
PCR products were purified by agarose gel electropho-
resis and extraction with Geneclean II (BIO101). Direct
sequencing of PCR products was performed with a dye-
terminator cycle-sequencing kit (Perkin-Elmer) using
Taq FS DNA polymerase. Sequences were resolved on
an ABI PRISM 377 automatic sequencer, and the results
were analyzed with the ABI Analysis software (version
2.1).
Microsatellite and RFLP Analysis
Analysis of polymorphisms at theHGO-1 (D3S4496),
HGO-2 (D3S4497), and HGO-3 (D3S4556) microsa-
tellites was performed by PCR, using total human ge-
nomic DNA, as described elsewhere. In brief, amplifi-
cation was performed in a total volume of 20 ml
containing 100 ng of genomic DNA; 5 pmol of each
primer (see table 3); 1 U Taq polymerase (Perkin-Elmer
Cetus); 250 mM each dATP, dGTP, and dTTP; 10 mM
dCTP; 1 mCi a-[32P] dCTP at 300 Ci mmol1; 1.0 mM
MgCl2 (or 1.25 mM, in the case of HGO-3); 50 mM
KCl; and 10 mM Tris-HCl (pH 8.3). PCR conditions
were two cycles at 94C for 5 min, 60C for 1 min, and
72C for 1 min, followed by 30 cycles (or 25 cycles, in
the case of HGO-3) at 94C for 45 s and 60C for 40
s. Samples were resolved on 6% polyacrylamide se-
quencing gels (or 8%, in the case of HGO-3) and were
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Table 2
HGO Mutations Identified in AKU Patients
Mutation Type
Nucleotide
Changea
Amino Acid
Change/Predicted
Consequence
No. of
Families
Country or
Countries of
Origin Reference
F10 fs Frameshift c198GGrATT Truncation after
Phe10
1 France Present report
E42A Missense c292ArC Glu42Ala 1 UK Present report
W97G Missense c456TrG Trp97Gly 1 France Present report
IVS51GrT Splice site c5091GrT Aberrant splicing 1 Holland Present report
G152 fs Frameshift c621insG Truncation after
Gly152
2 Slovakia Gehrig et al.
(1997)
D153G Missense c625ArG Asp153Gly 1 France Present report
G161R Missense c648GrA Gly161Arg 1 Slovakia Gehrig et al.
(1997)
S189I Missense c733GrT Ser189Ile 1 Algeria Present report
I216T Missense c814TrC Ile216Thr 1 Spain Present report
IVS9-56GrA Intron change c817-56GrA ? 2 Italy and
France
Present report
IVS9-17GrA Intron change c817-17GrA ? 1 Italy Present report
R225H Missense c841GrA Arg225His 1 Spain Present report
F227S Missense c847TrC Phe227Ser 1 Spain Present report
P230S Missense c855CrT Pro230Ser 3 Spain (2) and
Turkey
Fernandez-
Can˜o´n et al.
(1996)
V300G Missense c1066TrG Val300Gly 3 France, Spain,
and
Germany
Fernandez-
Can˜o´n et al.
(1996)
M368V Missense c1269ArG Met368Val 2 Germany and
France
Present report
a Positions of nucleotide changes are from the transcription start site as described in Granadino et al. (1997). The ATG initiation codon is
located at nucleotide position c168. The complete nucleotide sequence of the humanHGO transcript has been deposited under accession number
AF045167.
exposed on Kodak XAR film, with intensifying screens
at 70C, for 2–12 h.
SSCP Analysis
SSCP analysis was performed by PCR, using total ge-
nomic DNA, as described elsewhere (Orita et al. 1989).
In brief, amplification was performed in a total volume
of 10 ml containing 100 ng of genomic DNA; 12.5 pmol
of each primer (see tables 1 and 2); 1 U Taq polymerase;
250 mM each dATP, dGTP, and dTTP; 10 mM dCTP; 1
mCi a-[32P]-dCTP at 300 Ci mmol1; 1.5 mM MgCl2;
50 mM KCl; and 10 mM Tris-HCl (pH 8.3). PCR con-
ditions were one cycle at 94C for 2 min and 30 cycles
of 94C for 1 min, 60C for 1 min, and 70C for 1 min.
Samples were resolved on 8% and/or 10% nondena-
turing polyacrylamide gels and were exposed on Kodak
XAR film, with intensifying screens at 70C, for 2–10
h.
References for Links among Databases
The gene for alkaptonuria (AKU [MIM 203500]),
HGO, codes for homogentisate 1,2 dioxygenase. The
complete nucleotide sequences for the humanHGO gene
(54,363 bp) and its transcript (1,715 bp) have been de-
posited under GenBank accession numbers AF000573
and AF045167, respectively.
Results
Mutations in HGO in AKU Patients
Fourteen unrelated AKU patients and two obligate
carriers, children of another AKU patient, were screened
for mutations in the HGO gene. This represents a total
of 29 novel AKU chromosomes. All 14 exons of the
HGO gene, including their flanking intronic sequences,
were amplified from the genomic DNA of each AKU
patient by use of the PCR primers specified in table 1.
SSCP analysis was performed on exons 1, 2, 3, 4, 5, 7,
8, and 13, and any exons presenting band shifts were
subsequently sequenced. All remaining exons—6, 9, 10
11, 12, and 14—were sequenced in both strands.
Twelve novel HGO mutations were identified in 21
of the 29 AKU chromosomes examined. Eight of them
were missense mutations, resulting in the following
amino acid substitutions: E42A, W97G, D153G, S189I,
I216T, R225H, F227S, and M368V; one, F10fs, was a
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Figure 1 Localization of the AKU mutations and intragenic polymorphic markers at the human HGO locus. The human HGO gene is
shown as a thick horizontal line, with the exons indicated by short, thick vertical lines and labeled 1–14. Above the structure of the HGO
gene, the thin lines localize the position of each of the 16 AKU mutations characterized thus far. Asterisks indicate mutations that have been
described elsewhere (Ferna´ndez-Can˜o´n et al. 1996) but have been encountered again in the 29 AKU chromosomes included in the present study.
Double asterisks indicate mutations found in a study of AKU patients from Slovakia (Gehrig et al. 1997). Below the structure of the HGO
gene, the thin lines show the relative positions of seven intragenic polymorphic sites. HGO-1, HGO-2, and HGO-3 are dinucleotide repeats.
IVS235T/A, c407T/A, IVS525T/C, and IVS646C/A are SNPs. c407T/A is a relatively frequent nucleotide substitution in the coding sequence
(exon 4), causing an amino acid change (H80Q). HGO-1 (D3S4496) and HGO-2 (D3S4497) have been reported elsewhere (Granadino et al.
1997). Distances are drawn to scale.
frameshift mutation (198GGrATT), two were intronic
mutations (IVS9-56GrA, IVS9-17GrA), and one was
a splice-site mutation, IVS51GrT (table 2 and fig. 1).
In addition, five AKU chromosomes harbored loss-of-
function mutations that have been described, elsewhere,
in two Spanish pedigrees (Ferna´ndez-Can˜o´n et al. 1996).
Thus, the AKU chromosomes from a German consan-
guineous pedigree and one AKU chromosome from
France carried the V300G mutation. Similarly, the AKU
chromosomes in a Turkish consanguineous pedigree had
the P230S mutation. In the remaining 3 of the 29 AKU
chromosomes (10%), no mutation was detected, how-
ever. Two mutations, G161R and G152fs, described,
elsewhere, in three Slovak pedigrees (Gehrig et al. 1997)
were not found in our group of AKU patients.
None of the 12 novel mutations was observed in a
sample of unaffected control individuals, including x80
chromosomes, and none was coincident in the same hap-
lotype with other HGO mutations, which suggests that
these changes do not represent frequent polymorphisms.
All of the novel missense mutations change amino acid
residues that are conserved between humans and other
species (i.e., Aspergillus nidulans [Ferna´ndez-Can˜o´n et
al. 1995] and/or Mus musculus [Schmidt et al. 1997]).
Mendelian inheritance of the mutations was confirmed
by SSCP and/or sequence analysis of the relevant am-
plified DNA fragment in family members (data not
shown).
Polymorphic Sites within the Human HGO Gene
We have recently described the characterization of two
SSRs within the HGO gene, a (CT)n repeat in intron 4
(HGO-1, D3S4496), and a (CA)n repeat in intron 13
(HGO-2, D3S4497) (Granadino et al. 1997). Here we
report the identification and analysis of five additional
polymorphic sites at the HGO locus. These novel poly-
morphic sites correspond to a variable dinucleotide re-
peat (HGO-3) and four single-nucleotide polymor-
phisms (SNPs), IVS235T/A, c407T/A, IVS525T/C,
and IVS646C/A (fig. 1). HGO-3 (D3S4497) is a per-
fect (CA)n repeat located within the 17,687-bp–long in-
tron 4 of HGO that was encountered during inspection
of the 54-kb–long sequence of the human HGO gene
(Granadino et al. 1997). The IVS235T/A, c407T/A,
IVS525T/C, and IVS646C/A polymorphisms were
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Table 3
Novel Polymorphic Markers within the HGO Gene
Marker Type HET PIC Primer Sequences Allele FRQ
HGO-3
(D3S4556)
(CA)n .84 .82 F: GGAGGCAACTTTAGGACAAACTTG
R: CACCCATAAAATTTCCGCTCATCC
175
177
187
189
191
193
195
197
199
201
.008
.008
.085
.208
.192
.200
.100
.123
.062
.015
IVS2 35A/T Single base change
(intron 2)
.32 .27 F: CATATAGGAATTCTTACCTTAGTAAACTGC
R: GGCAGATCTTTGGCCTGAAAGCTAGT-
CATCC
A
T
.80
.20
IVS5 25T/C Single base change
(intron 5)
.21 .19 F: GATGCTATTTATTTAGAAGGTC
R: GCTTTTGCTTGGCATTCAGGCTGCAAATGG
T
C
.88
.12
IVS6 46C/A Single base change
(intron 6)
.40 .32 F: CATTTTCCTCTGCAATACCTCCATGGAG
R: CAACTATGTATGTGCATATGTGAC
C
A
.72
.28
c407T/A
(H80Q)
Single base change
(exon 4)
.30 .25 F: ACTCTAAGGCTTGTATATCTTGTAT
R: TTCCAATGACCATGGTATTC
T
A
.82
.18
NOTE.—HET indicates heterozygosity; FRQ, frequency; PIC, polymorphism information content.
identified by DNA sequencing while searching for mu-
tations in AKU patients. They were excluded from being
AKU mutations because of their elevated frequencies in
the normal population. IVS235T/A, IVS525T/C,
and IVS646C/A are SNPs located withinHGO introns
2, 5, and 6, respectively. The c407T/A site is located in
exon 4. It corresponds to a relatively frequent T/A var-
iation in the coding sequence, changing a conserved his-
tidine (CAT), at amino acid position 80, for a glutamine
(CAA). c407T/A is, therefore, an H80Q protein poly-
morphism. Allele frequencies at the IVS235T/A,
c407T/A, IVS525T/C, IVS646C/A, and HGO-3
sites were determined in a sample of 52 normal Spanish
individuals and are shown in table 3.
Haplotype Analysis of Polymorphic Sites within the
HGO Gene
Haplotype associations between alleles at seven poly-
morphic sites within the HGO gene were initially es-
tablished for a total of 104 chromosomes. This analysis
included the HGO-1 and HGO-2 sites described else-
where (Granadino et al. 1997). However, as could be
expected, the haplotypes generated from this small sam-
ple of chromosomes are almost all unique. The very large
number of different HGO haplotypes in our sample is
mostly due to the very polymorphic microsatellite re-
peats HGO-2 and HGO-3. Thus, to eliminate excessive
variability in the analysis and to obtain useful infor-
mation about the genetic structure of the Spanish pop-
ulation at theHGO locus, we did not consider variation
at these two sites.
The analysis of the haplotypic associations of alleles
at the IVS235T/A, c407T/A, HGO-1, IVS525T/C,
and IVS646C/A polymorphic sites demonstrated that
our population is composed of five major HGO hap-
lotypes, which we called A, B, C, D, and E (table 4).
The most frequent haplotype is A (∼60%), followed by
B and C (each ∼10%) and then by D and E (each ∼7%).
As indicated above, each of these haplotypes shows con-
siderable variability at the HGO-2 and HGO-3 sites.
However, as indicated in table 4, particularHGO-2 and
HGO-3 alleles are found more frequently associated
with each of these haplotypes.
To establish the haplotypic associations between the
HGO polymorphisms and the AKU mutations, all seven
polymorphic markers (IVS235T/A, c407T/A, HGO-
3, HGO-1, IVS525T/C, IVS646C/A, and HGO-2)
were characterized in the AKU patients and their fam-
ilies. A complete description of theHGO haplotypes for
33 AKU chromosomes, including two pedigrees reported
elsewhere (Ferna´ndez-Can˜o´n et al. 1996), is presented
in table 5.
Discussion
We reported, elsewhere, that theHGO gene is the gene
for AKU, and we described two loss-of-function muta-
tions, P230S and V300G, in two unrelated Spanish AKU
pedigrees (Ferna´ndez-Can˜o´n et al. 1996). The P230S
mutation was found in three of the four AKU chro-
mosomes included in the original report, which suggests
that P230S was a highly prevalent mutation, perhaps
characteristic of the Spanish population. The analysis of
29 additional AKU chromosomes—from France (9),
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Table 4
Most Representative HGO Haplotypes in the Normal Population
Name
Approximate
Frequency IVS235A/T c407A/T HGO-3a HGO-1 IVS525T/C IVS646A/C HGO-2a
A .60 A T(A) 189
193
195
197
161 T C 181
187
B .10 A T 189
191
161 T A 179
C .10 T T 191 161 T A 179
D .07 T T 191 161 T C )b
E .07 A T 189
193
163 C A 187
a HGO-2 and HGO-3 alleles that are found predominantly associated to each of the HGO haplotypes.
b No specific allele was found associated with this haplotype.
Spain (6), Germany (4), Italy (2), the United Kingdom
(2), Holland (2), Algeria (2), and Turkey (2)—demon-
strates a large heterogeneity of HGO mutations and no
prevalence of any single AKU mutation. Thus far, a total
of 39 AKU chromosomes, including those in five AKU
pedigrees that have been described elsewhere (Ferna´n-
dez-Can˜o´n et al. 1996; Gehrig et al. 1997), have been
screened for mutations in HGO. Although the number
of AKU chromosomes is still small, the count of 16 dif-
ferent mutations identified is notable (table 2). P230S,
V300G, and M368V are relatively common mutations
that are present in AKU chromosomes from different
geographical regions. However, none of these mutations
is present in 115% of the AKU chromosomes. Interest-
ingly, only a small percentage (9%, 3 of 33) of the AKU
chromosomes analyzed in our laboratory showed no
candidate mutation. All of the AKU chromosomes in
which no mutation has been identified belong to patients
who present, in the other chromosome, one of theHGO
mutations depicted in table 2, which suggests that these
patients are indeed compound heterozygotes for muta-
tions in HGO and that there is no genetic heterogeneity
in AKU. Experiments are being performed to charac-
terize HGO internal deletions or aberrant splicing in
these patients.
In this report, a total of 12 novel mutations are de-
scribed (table 2). Most of these are missense mutations,
changing amino acid residues that are conserved be-
tween humans and other species. The effects of these
novel mutations on the function of the HGO protein are
currently unknown, although experiments are in pro-
gress to address this question. Among the novel muta-
tions described here, F10fs is an insertional substitution
(198GGrATT) resulting in a1 frameshift, after Phe10,
that should result in truncation of the HGO polypeptide
two residues downstream. Therefore, the F10fsmutation
almost certainly represents a null allele. IVS51GrT is
a splice-site mutation that should alter the correctHGO
splicing and that probably results in exon skipping and
truncation of the HGO polypeptide. The consequences
of the IVS9-56GrA and the IVS9-17GrA mutations
are, however, more difficult to foresee. The IVS9-56GrA
mutation was found in heterozygosis in two unrelated
AKU patients. One of them carries the IVS9-17GrA
mutation in the other chromosome. Like all other novel
mutations described here, the IVS9-56GrA and IVS9-
17GrA mutations were not found in a sample of 80
unaffected chromosomes, which indicates that they are
not frequent polymorphisms. We cannot rule out the
possibility that the IVS9-56GrA and IVS9-17GrA mu-
tations are, however, rare polymorphisms in strong link-
age disequilibrium with another not-yet-identified mu-
tation that would be the true causative mutation in these
AKU chromosomes. To test whether these mutations
prevent the correct mRNA splicing, reverse transcrip-
tase–PCR analysis of the HGO mRNA from these pa-
tients is being performed.
The mutations thus far characterized in AKU patients
are distributed throughout the whole length of theHGO
gene sequence (fig. 1). It is noticeable, however, that 7
of the 11 missense HGO mutations are clustered within
exons 7–10 and that 3 of these mutations change amino
acid residues at positions 225, 227, and 230, within exon
10. These data point to this short peptide region encoded
by exon 10 as crucial for the enzymatic activity of HGO.
The analysis of the haplotypic associations of alleles
at the IVS235T/A, c407T/A, HGO-1, IVS525T/C,
and IVS646C/A polymorphic sites demonstrated the
presence of five major HGO haplotypes in our popu-
lation sample (table 4). Observed frequencies for the
HGO-A, HGO-B, HGO-C, and HGO-D haplotypes
are not different from those expected, if we consider the
allele frequencies at the IVS235T/A, c407T/A, HGO-
1, IVS525T/C, and IVS646C/A sites. The HGO-E
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Table 5
HGO Haplotypes Associated to the AKU Alleles
MUTATION
FREQUENCY
(n  33)
ASSOCIATED POLYMORPHISMS
IVS235A/T c407T/A HGO-3 HGO-1 IVS525T/C IVS646A/C IVS-9 HGO-2 Origina
P230S 5 A T 189 163 C A 817-38insA 185 Spain (1a)
A T 189 163 C A 817-38insA 185 Spain (1b)
A A 191 163 C A 817-38insA 185 Spain (2a)
T T 191 163 C A 817-38insA 185 Turkey (3a)
T T 191 163 C A 817-38insA 185 Turkey (3b)
S189I 2 A T 189 163 C A 185 Algeria (4a)
A T 189 163 C A 185 Algeria (4b)
V300G 4 A T 189 163 C A 187 France (5a)
A T 189 163 C A 187 Germany (6a)
A T 189 163 C A 187 Germany (6b)
A T 189 163 C A 187 Spain (2b)
M368V 3 A T 195 161 T C 183 Germany (7a)
A T 195 161 T C 183 Germany (7b)
T T 195 161 T C 181 France (5b)
E42A 2 A A 193 161 T C 187 UK (8a)
A A 193 161 T C 187 UK (8b)
IVS51GrT 2 T T 191 161 T C 183 Holland (9a)
T T 191 161 T C 183 Holland (9b)
IVS9-56GrA 2 A T 195 161 T C 181 Italy (10a)
A T 195/199 161 T C 181 France (11a)
IVS9-17GrA 1 A T 189 161 T C 191 Italy (10b)
I216T 1 A A 193 161 T C 187 Spain (12a)
D153G 1 A/T T/A 195/191 161 T C 187/183 France (13a)
W97G 2 T T 191 161 T A 179 France (14a)
T T 191 161 T A 179 France (14b)
R225H 2 T T 191 161 T A 183 Spain (15a)
T T 191 161 T A 179 Spain (15b)
F227S 2 A T 197 161 T A 181 Spain (16a)
A T 197 161 T A 181 Spain (16b)
F10 fs 1 T T 191 161 T A 181 France (17a)
Unknown 3 A T 199/195 161 T C 181 France (11b)
A T 189 161 T C 183 France (17b)
T T 193 161 T C 181 Spain (12b)
a The chromosomes for each of the AKU patients are indicated in parentheses (i.e., patient 1, chromosomes 1a and 1b).
haplotype, however, appears with a higher frequency
than that expected from the individual allelic frequen-
cies. In fact, this haplotype is interesting because it il-
lustrates a situation of strong linkage disequilibrium be-
tween the uncommon HGO-1(163), IVS525C, and
IVS646C/A alleles in our population ( ;D  66.9#1000
). Frequencies for these alleles are 0.092, 0.12,P ! .001
and 0.28, respectively.
To test whether these HGO haplotypic frequencies
were specific to the Spanish population, we also obtained
data for the HGO intragenic polymorphisms, and we
analyzed the haplotypic associations between alleles at
four of these sites in an additional population of 46
normal Italian chromosomes. This analysis showed no
significant differences between the normal Spanish and
Italian samples for the frequencies of the alleles at the
HGO intragenic markers or their haplotypic associa-
tions (data not shown).
There are various possible mechanisms leading to non-
random associations of alleles that can explain the un-
expectedly elevated frequency of the HGO-E haplotype
in our population. These include selective advantage,
random genetic drift, inbreeding, and emigration with
amalgamation of population. Analysis of different Eur-
opean and North African populations should help to
clarify this point.
The association between AKU mutations and HGO
haplotypes is very strong, although some variability can
be detected at the HGO-2 and HGO-3 sites and occa-
sionally at the IVS235T/A and c407T/A sites (table
5). In all four P230S chromosomes that we have iden-
tified thus far, a segment of the HGO haplotype span-
ning the HGO-1, IVS525T/C, IVS646A/C, IVS9-
38insA, and HGO-2 loci is fully conserved, with iden-
tical alleles in all these sites. This segment includes exon
10, with the P230S mutation (fig. 1 and table 5). These
data strongly argue against P230S being a recurrent mu-
tation and support the idea that these four P230S chro-
mosomes are phylogenetically related. Variation at the
markers upstream of the HGO-1 site (IVS235T/A,
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c407T/A, andHGO-2) in these AKU chromosomes sug-
gests that P230S is a relatively old mutation. Accord-
ingly, differences among the P230S chromosomes at the
HGO-3 site are probably a reflection of the relatively
high rate of mutation at microsatellite sites (103 per
locus per gamete per generation) (Weber and Wong
1993), whereas changes at the IVS235T/A and c407T/
A dimorphic sites, with an expected mutation rate of
109 per site per year, would be better explained by
recombination events. A similar explanation is probably
true for the variation in the haplotypes associated to the
M368V mutation (table 5), which is also interpreted as
an old AKU mutation.
The V300Gmutation is a relatively commonmutation
that, like P230S and M368V, has been encountered in
more than one geographical region (table 5). Although
one of the individuals carrying this mutation belongs to
a consanguineous pedigree, it is interesting that the
V300G mutation has been found in all instances to be
associated with the sameHGO haplotype, with identical
alleles in all seven polymorphic sites. Again, this argues
in favor of a common origin for the AKU chromosomes
carrying the V300Gmutation. The fact that no variation
is detected among these AKU chromosomes suggests that
V300G originated more recently than P230S.
We have discussed, above, the peculiarities of the
HGO-E haplotype and have indicated that the strong
linkage disequilibrium between the uncommon HGO-
1(163), IVS525C, and IVS646A alleles can be ex-
plained by, among other mechanisms, emigration, with
population admixture. It is interesting, in this context,
that two relatively common AKU mutations, P230S and
V300G, are associated with the HGO-E haplotype and
that these mutations have been encountered at various
geographical locations, including Spain, France, Ger-
many, and Turkey. Furthermore, it is also noticeable that
the S189I mutation, encountered in homozygosis in an
Algerian pedigree, is also associated with the HGO-E
haplotype (table 5), perhaps suggesting that the HGO-
E haplotype is frequent in this NorthAfrican population.
Several migrations have contributed to the present
Spanish population. These include that of the Capsians,
who populated northern Africa and southern Europe
20,000 years ago, several migrations from the Sahara
around 8,000 years ago, and that of the Arabs, who
spread widely throughout the Middle East and northern
Africa and who entered the Iberian Peninsula in the 7th
century (Ramos-Oliveira 1971). It is tempting to spec-
ulate that the HGO-E haplotype was introduced in
southern Europe by one of these migrations and that the
P230S mutation, and perhaps also the V300Gmutation,
originated in that population prior to its migration into
Europe.
The data presented in this article represent the first
extensive account of AKU mutations and associated in-
tragenic polymorphisms, and they provide a general un-
derstanding of the variability at the HGO locus in both
AKU and normal populations. This knowledge should
be useful for the identification of AKU alleles and for
tracing their migration during recent human history.
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